OLD Category: colon

Faecal micro-RNAs in inflammatory bowel diseases

• Verdier J et al.,

Expression Profiling Reveals Involvement of WNT Pathway in the Malignant Progression of Sessile Serrated Adenomas

• Nourbakhsh M et al.,

Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis

• Boden EK et al.,

Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn’s Disease and Ulcerative Colitis Patients

• Bsat M et al.,

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes

• Ragulan C et al.,

Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells

• Ndreshkjana B et al.,

Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy

• Vázquez-Arreguín K et al.,

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

• Perez-Ruiz E et al.,

Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)

• Lenz HJ et al.,

A Clinical Applicable Gene Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer

• Piskol R. et al.,

Increasing Incidence of Colon Cancer in the Young: Assessing the Tumor Biology

• Nfonsam V.N. et al.,

IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease

• Belarif L. et al.,